Global Therapeutic Drug Monitoring Market Size, Status and Forecast 2021-2027

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.
Roche, Danaher and Abbott are the major companies in the industry, accounting for 17.17%, 10.36% and 8.29% of the revenue respectively in 2019. By region, North America had the highest share of income, reaching 42.31 percent in 2019.

Market Analysis and Insights: Global Therapeutic Drug Monitoring Market
The global Therapeutic Drug Monitoring market size is projected to reach US$ 2440.4 million by 2027, from US$ 1616.9 million in 2020, at a CAGR of 6.1% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Therapeutic Drug Monitoring market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Therapeutic Drug Monitoring market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Therapeutic Drug Monitoring market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Therapeutic Drug Monitoring market.

Global Therapeutic Drug Monitoring Scope and Market Size
Therapeutic Drug Monitoring market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Drug Monitoring market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Test
Urine Test
Saliva Test
Other Test
Blood test is one of the largest product segments of the polyurethane market, accounting for over 50% revenue market share in 2019.

Segment by Application
Hospital Labs
Private Labs
Others
Hospital labs holds an important share in terms of applications with a sales market share of over 50% in 2018.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthcare
Bio-Rad Laboratories
BioMerieux
Sanquin
Becton Dickinson
Quest Diagnostics